MKM Upgrades Merck to a “Buy” (MRK)

By
A A A
Share |

MKM reported on Tuesday that they have upgraded healthcare company, Merck & Co., Inc.( MRK ) to a "Buy".

The firm reported that they have upgraded MRK from "Neutral" to a "Buy," and have given the company a price target of $51. This price target suggests a 15% increase over the stock's current price of $43.38.

Merck & Co. shares were mostly flat during premarket trading Tuesday. The stock is up 14.96% YTD.

The Bottom Line
Shares of Merck ( MRK ) have a 3.81% dividend yield, based on last night's closing stock price of $43.34. The stock has technical support in the $41-$42 price area. If the shares can firm up, we see overhead resistance around the $46-$48 price levels.

Merck & Co., Inc.( MRK ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: MRK

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

48,099,947
  • $16.09 ▲ 0.50%
40,277,806
  • $102.50 ▲ 0.24%
40,236,499
  • $19.57 ▲ 2.35%
31,092,510
  • $49.75 ▲ 0.65%
30,795,218
  • $34.92 ▲ 0.78%
29,910,855
  • $3.63 ▲ 0.83%
24,019,154
  • $13.06 ▼ 0.38%
23,753,906
  • $74.82 ▲ 1.31%
As of 8/29/2014, 04:04 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com